Additional file 7 of An antibody-drug conjugate targeting soluble and membrane-bound TGFα is effective against pancreatic tumors

Supplementary Material 7: Fig. 7. A. Expression levels of total and active EGFR pancreatic cancer cell lines. One milligram of total protein from each cell line was immunoprecipitated with an anti-EGFR antibody to assess both the total amount and the phosphorylation status of EGFR. Calnexin was used as a loading control. B. Relationship between TGFA and EGFR expression in pancreatic cancer. Data was obtained from the TNMplot online tool.